Symptoms and signs of congestion are the main reasons for hospitalization of acute heart failure patients. Loop diuretics are recommended, but their response is variable. Blockade of nephron has been proposed as a more effective strategy. Two large-scale trials examined this hypothesis, targeting the proximal and distal tubules respectively. Results were discussed in the context of previous studies and ultrafiltration.
Symptoms and signs of congestion are the primary reason for hospitalization of patients with acute heart failure. Efficient fluid and sodium removal remains the main goal of therapy and loop diuretics are the recommended agents in this setting. However, the therapeutic response to these medications is known to be variable and a significant subset of patients are discharged from the hospital with residual fluid overload. Therefore, sequential blockade of nephron has been proposed as a more effective decongestive strategy. Pilot studies have suggested significant increase in diuresis and natriuresis with combination diuretic therapy. Recently, two groups of investigators examined this hypothesis on a larger scale in randomized placebo-controlled trials; one targeted the proximal tubules upstream of the loop of Henle (Acetazolamide in Decompensated Heart Failure with Volume Overload - ADVOR) while the other one blocked sodium-chloride cotransporters in the distal convoluted tubules (Combination of Loop with Thiazide Diuretics for Decompensated Heart Failure - CLOROTIC). Herein, we discuss the results of these two trials with special focus on their impact on extraction of sodium, i.e. the main determinant of extracellular volume, and put them in the context of previous studies of combination diuretic therapy as well as extracorporeal ultrafiltration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据